MOG and myeloid sarcoma: Considering the absence of anti-aquaporin-4 (anti-AQP4) or anti-myelin oligodendrocyte glycoprotein (anti-MOG) antibodies in our patient, as well as the absence of clinical or serologic evidence for other systemic autoimmune disease, the leading differential diagnosis in our patient is MS.